
The Role of the Laboratory in Diagnosis and Management of Inhibitory Antibodies in Hemophilia
In the Monday morning session entitled Inhibitors: Clinical Aspects, Jan Astermark described the different diagnostic assays laboratories can carry out
Year: 2018
Language: English
Author(s): Jenny Goudemand, Manuel Carcao
Format: Document
This resource has also been translated into the following languages, with permission from the WFH, by NMOs: Traditional Chinese
Inhibitors are a serious complication of hemophilia caused by an immune response to clotting factor concentrates. Treatment of inhibitors is one of the biggest challenges in hemophilia care today. This primer explains our current understanding of how and why inhibitors form, reviews the established approaches to managing inhibitors, and looks ahead to some potential future developments in the field.

In the Monday morning session entitled Inhibitors: Clinical Aspects, Jan Astermark described the different diagnostic assays laboratories can carry out

The accurate diagnosis of von Willebrand disease (VWD) is crucial to its management. This resource describes laboratory tests based on

The accurate diagnosis of von Willebrand disease (VWD) is crucial to its management. This resource describes the techniques used to

In the Monday afternoon session on alternative therapies in the management of inhibitors, Rebecca Kruse-Jarres discusses the latest developments in

In the Monday afternoon session on alternative therapies in the management of inhibitors, David Lillicrap explores the mechanisms of tolerance

Genetic counselling constitutes an integral part of the comprehensive hemophilia care team providing people with hemophilia, and their families, clinical